Services

How can we help you

CoVelocity is a commercialization cooperative dedicated to bridging the needs of the public sector and technologies developed by innovators. 

49304486477_4b7f930eb0_o

Flexible, responsive, and tailored to your unique needs.

We've founded medtech companies, accelerated clinical validation for existing products, and build commercial infrastructure for solutions with regulatory approval. Whether your company has yet to be incorporated or you're scaling sales globally, our team can help you reach your targets to ensure your solution is able to improve lives, worldwide.

For Early Stage Innovation

  • Getting to Proof-of-Concept: great ideas deserve to be proven well. We work with early-stage companies to find the right partners to run pre-clinical validation to establish proof-of-concept, quickly.
  • Clinical Validation and Regulatory Approval: clinical trial stakeholder alignment, CRO hand-holding, regulatory pathway strategies, local regulatory processes.

For Scaling Companies

  • Executive Services: time or project-bound executive functions (C-level, Sales, marketing, customer success, operations) for your company.
  • Business Development: Go-to-market strategy, Key-Opinion-Leader engagement, Distributor management, B2B and B2C sales
  • Customer Success: Customer journey design, engagement metrics, strategic customer identification, technical support infrastructure, smart satisfaction surveys.
  • New Product Introduction

For Health Providers and Distributors

  • Strategic Sources: Support health-care providers and medical distributors get the innovative technologies they need to save more lives.

Examples of our work

When COVID19 spread across the world, many countries were caught at the back of the multinational diagnostics’ company’s order list. This left health systems across the globe without the tools they needed to diagnose SARS-CoV-2.

In Guatemala, the pioneering foundation FUNDESA - the Foundation for the Development of Guatemala - partnered with CoVelocity to identify a molecular diagnostics platform that could enable the government of Guatemala to successfully respond to the pandemic. CoVelocity set out to identify, validate and make available a high quality yet low-cost and easy to use COVID19 PCR test: Atila Biosystems’ iAMP RT-PCR solution.

Since then, CoVelocity has expanded availability of Atila Biosystems’ revolutionary molecular diagnostics technology to multiple markets where its advantages in cost, simplicity, and speed are critical for scaling diagnostic testing.

In April 2021, India was plunged into an oxygen crisis by the rising Delta variant of COVID19. GenWorks Health, an Indian healthcare distribution company, partnered with CoVelocity to rapidly source oxygen concentrators for the Indian market.

Within less than a week, CoVelocity identified multiple sources for the Indian market that met their quality and price guidelines, including Israel’s Chaban Medical, a leading expert in quality engineering, who worked with the Israeli government to ensure the concentrators were able to arrive when they were needed most.

Since then, CoVelocity has worked closely with Chaban Medical to introduce their high quality, affordable healthcare technologies to markets who can benefit from their attention to detail and understanding of the health system’s needs.